Employer GLP-1 care, done right. Clinically supported programs that keep employees healthy and businesses thriving.
Joined October 2021
- Tweets173
- Following239
- Followers4.8K
- Likes58
eMed retweeted
@eMedHealth is leading the charge in healthcare transformation, and the FQ Health Summit was just the beginning. Now healthcare needs to move at the speed we deserve. @eMedHealth and the @femalequotient kicked off the Next Era of Women's Health with @SheMed_UK founders Chloe & Olivia Ferro, & @ShelleyZalis.
eMed retweeted
We thought GLP-1s were about the scale. Turns out they’re rewriting the history of our health! Heart, kidney, liver, joints, sleep, addiction. Once-in-a-lifetime medicines. The list is still growing. @EricTopol
eMed retweeted
Employees are frustrated, even angry right now. Employers cutting GLP-1 coverage to save money are being short sighted. Losing access to medication people rely on isn't an option.
GLP-1s are essential modern healthcare, and they reduce long-term costs too.
Ask your employer about @eMedHealth.
bloomberg.com/news/articles/…
eMed retweeted
GLP-1s have changed what's possible in healthcare, and employees are counting on them.
Employers should be expanding access, not cutting it. That's exactly what @eMedHealth was built for.
washingtonpost.com/business/…
eMed retweeted
Betting on yourself. Writing your own playbook. Building @eMedHealth.
That's what I got into with @LizClaman.
Listen here: podcasts.apple.com/us/podcas…
eMed retweeted
Bank of America CEO Brian Moynihan is right to raise the question of GLP-1 costs.
But here's the bigger question every employer should be asking: What's the cost of doing nothing?
Chronic disease is already one of the largest costs facing employers.
The medication is the catalyst, not the strategy.
The organizations that come out ahead will focus on outcomes, adherence, and long-term health, not just pharmacy spend.
cnbc.com/2026/08/05/bank-of-…
eMed retweeted
The payoff for GLP-1s comes from staying on the medications. That's why employer coverage needs to expand. @eMedHealth
Most employer GLP-1 coverage stops at diabetes and weight loss.
But the drugs are being studied for cardiovascular, liver, kidney disease, and more.
Susan Thomas of @LucyRx on where coverage still falls short: hubs.li/Q04qFtZp0
#GLP1 #EmployerBenefits #PharmExec
eMed retweeted
We don't measure success by prescriptions. We measure it by outcomes.
I joined @TomBrady and @LizClaman on @FoxBusiness today to talk about exactly that.
The question used to be "should we cover GLP-1s?"
That conversation is over. Now it's "how can you NOT cover them?"
Enter @eMedHealth
eMed retweeted
30% average weight loss. GLP-1s work.
But only if your program keeps people on them long enough to prove it.
Medication without accountability is an expense.
Medication with clinical oversight is an investment with incredible returns.
That's the difference. That's @eMedHealth.
eMed retweeted
1 in 10 people globally interact with AI weekly.
1 IN 8 AMERICANS ARE ON A GLP-1. Finally, healthcare DEFLATION.
While AI is reshaping how we do things, GLP-1s are reshaping human biology. And their convergence offers something the US healthcare system has never experienced in its entire history. As Eric Larsen points out, this is not a trend. This is a restructuring of humanity. @eMedHealth
eMed retweeted
🚨 New study: GLP-1 users save an average of $193,000 in lifetime medical costs.
@beckershr reports 75% of health plan providers still don't cover them.
The math has never been clearer. The resistance has never been harder to defend. bit.ly/4b5DHDk
eMed retweeted
When adherence is maintained with GLP-1 medications, health outcomes improve and financial outcomes follow.
At @eMedHealth we are seeing a high adherence rate - the result of a structured program that drives results. Grateful to @ariannahuff and Brooke Green of @aon_plc for a conversation every employer needs to hear right now
eMed retweeted
The headlines are focused on the wrong thing. You're not paying for GLP-1s.
You're paying for diabetes, cardiovascular disease, liver health, kidney health.
It's time to cover it. @eMedHealth
eMed retweeted
At our industry-leading Health Innovation Revolution Summit, Stanford professor Jeffrey Pfeffer said employers need to stop measuring what they spend and start measuring whether their employees are actually getting healthier. That one sentence is the entire problem with employer healthcare today. And it has a solution, @eMedHealth. Let's talk.
eMed retweeted
🎙️eMed Health Population CEO @lindayaX is now leading the charge at an up and coming GLP-1 player that just scored a big capital raise and has NFL legend @TomBrady as its founding chief wellness officer.
But, the time she spent rebuilding @elonmusk's X offered up a moment of reflection when we sat down on my Power Players podcast on @YahooFinance:
“When I first started [at X], I used to say that it was a career opportunity of a lifetime. And then I was there a couple of weeks and I dropped the career part and I said, it's just an opportunity of a lifetime. And again, I go back to my time of what we did, of repositioning the platform to become the global town square. And I say for the world, it was like turning a light bulb on and in a dark room. And, and so who wouldn't want to be part of that? But as you know, it was at a very tumultuous time. Transformation is always messy. And when it's messy, people that you think you've known your whole career or people that you've done business with, it takes them a little while to warm up to what you're doing. So that's why even those relationships that I talked about mattered most,” Yaccarino said.
Tasked with stabilizing a platform in turmoil, Yaccarino is credited with modernizing X’s business operations, spearheading the expansion of video features and digital wallet services, and working tirelessly to bring back advertisers.
Our full chat 👇
📈Yahoo Finance: finance.yahoo.com/video/why-…
🎙️Spotify: open.spotify.com/episode/5wp…
🎧Apple: podcasts.apple.com/us/podcas…
🎵Amazon: music.amazon.com/podcasts/7b…
eMed retweeted
At @SXSW, @mcuban and I shared that @eMedHealth and @costplusdrugs are working together to give eMed members access to GLP-1s through the Cost Plus Drugs Affiliate Pharmacy Network. Transparent pricing + a system designed for results. This is healthcare disruption.
eMed retweeted
Big announcement from @emedhealth today! Welcome to the Fam @TomBrady- our Founding Chief Wellness Officer! Hear from the GOAT himself. Let’s GO!
I'm proud to serve as @emedhealth’s Chief Wellness Officer. We're working on something that really matters, improving population health at scale so that people can feel better, perform better, and protect their long term health.
eMed retweeted
This is BIG! Tom Brady is @emedhealth today’s new Chief Wellness Officer. Tom built his career on discipline, performance, and longevity. Exactly what this moment in GLP-1 care demands. As Tom says: No shortcuts! bloomberg.com/news/articles/…
